Substance-Related Disorders: all 2,181 studies
Page 22 of 22. Open to participants first (399), then studies with results posted, then the rest; newest registration first within each.
- Telephone Enhancement Procedure for Continuing Care - 1CompletedNCT00067171Phase 3
- Preventing Problem Behavior Among Middle School StudentsCompletedNCT00062959Not applicable
- Substance Dependent Teens - Impact of Treating Depression Study 1 - 1CompletedNCT00061113Phase 4
- The Maternal Lifestyle Study (MLS)CompletedNCT00059540
- Improving Substance Abuse Treatment Aftercare Adherence and OutcomeCompletedNCT00057187Not applicable
- Onsite Versus Referral Models of Primary Care for Substance Abusing PatientsCompletedNCT00057096Not applicable
- Brain Function in Response to Motivational StimuliCompletedNCT00047866
- Family Intervention for Mental Illness and Substance AbuseCompletedNCT00043693Not applicable
- A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk ContactsCompletedNCT00038688Phase 3
- A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1Status unknownNCT00033124Phase 2
- A Study of Cabergoline for the Treatment of Cocaine Dependence - 1CompletedNCT00033111Phase 2
- Reserpine for the Treatment of Cocaine Dependence - 1CompletedNCT00033033Phase 2
- Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1CompletedNCT00033020Phase 3
- Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1CompletedNCT00033007Phase 3
- Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1CompletedNCT00032994Phase 3
- Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1CompletedNCT00032981Phase 3
- Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHDCompletedNCT00029614Phase 2
- Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1CompletedNCT00023283Phase 2
- Integrated Intervention for Substance Abusers With Depressive DisordersCompletedNCT00018655Phase 2
- Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14CompletedNCT00015340Phase 4
- Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11CompletedNCT00015301Phase 4
- Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9CompletedNCT00015275Phase 4
- Prepulse Inhibition of Startle in Cocaine Dependence - 7CompletedNCT00015249Phase 1
- Modeling Impaired Judgement in Cocaine Abusers - 6CompletedNCT00015236Phase 4
- Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5CompletedNCT00015223Phase 2
- Nefazodone in the Treatment of Cocaine Dependence and Depression - 4CompletedNCT00015210Phase 2
- Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1CompletedNCT00015171Phase 3
- Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2CompletedNCT00015041Phase 1
- Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1CompletedNCT00015028Phase 2
- Matching, Outcomes and Costs in Substance Abuse/Psychiatric TreatmentCompletedNCT00012727Phase 2
- Behavioral Economics of Human Drug Self-AdministrationCompletedNCT00005765
- Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)CompletedNCT00000388Phase 4
- Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7CompletedNCT00000358Phase 1
- Buprenorphine Maintenance for Opiate Dependence - 6CompletedNCT00000357Phase 2
- Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5CompletedNCT00000356Phase 2
- Effects of Buprenorphine and Naloxone in Opiate Addicts - 4CompletedNCT00000355Phase 1
- Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3CompletedNCT00000354Phase 1
- Trial of Buprenorphine/Naloxone for Opiate Dependence - 2CompletedNCT00000353Phase 2
- Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1CompletedNCT00000352Phase 2
- Cognitive Correlates of Substance Abuse, Part 2 - 16Status unknownNCT00000351
- Cognitive Correlates of Substance Abuse - 11Status unknownNCT00000346Phase 4
- Brain Changes in Stimulant Dependent Subjects - 8CompletedNCT00000343Phase 4
- Methamphetamine Abuse Treatment in Patients With AIDS - 1CompletedNCT00000321Phase 4
- Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2CompletedNCT00000319Phase 2
- Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1CompletedNCT00000318Phase 2
- Early Phase II Trials for Cocaine Medication Development - 1CompletedNCT00000317Phase 2
- Combining Behavioral Treatment With Agonist Maintenance - 1CompletedNCT00000311Phase 3
- Dextroamphetamine as an Adjunct in Cocaine Treatment - 1CompletedNCT00000304Phase 2
- Acute Withdrawal From Smoked Cocaine - 9CompletedNCT00000292Phase 1
- Pharmacotherapy for Schizophrenic Drug Users - 6CompletedNCT00000281Phase 2
- Novel Medications for Opiate Detoxification - 4CompletedNCT00000279Phase 2
- Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9CompletedNCT00000274Phase 2
- A Laboratory Model for Heroin Abuse Medications - 8CompletedNCT00000273Phase 2
- New Approaches to Cocaine Abuse Medications (A) - 6CompletedNCT00000271Phase 2
- Pergolide Treatment for Substance Abusers - 4CompletedNCT00000269Phase 2
- Subjective Effects of Nitrous Oxide in Dental Patients - 17CompletedNCT00000265
- Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16CompletedNCT00000264Not applicable
- Effects of Combined Alcohol and Nitrous Oxide Intake - 15CompletedNCT00000263Not applicable
- Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14CompletedNCT00000262Not applicable
- Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13CompletedNCT00000261Phase 2
- Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12CompletedNCT00000260Not applicable
- Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11CompletedNCT00000259Not applicable
- Role of Instructions in Nitrous Oxide Effects and Choice - 10CompletedNCT00000258Not applicable
- Effects of Alcohol History on Effects of Nitrous Oxide - 9CompletedNCT00000257Not applicable
- Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8CompletedNCT00000256Not applicable
- Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7CompletedNCT00000255Phase 2
- Isoflurane at Subanesthetic Concentrations - 6CompletedNCT00000254Phase 2
- Effects of Nitrous Oxide: A Dose-Response Analysis - 5CompletedNCT00000253Not applicable
- Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4CompletedNCT00000252Phase 2
- Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3CompletedNCT00000251Phase 2
- Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2CompletedNCT00000250Phase 2
- Effects of Subanesthetic Concentrations of Nitrous Oxide - 1CompletedNCT00000249Phase 2
- Rapid Benzodiazepine Detoxification Using Flumazenil - 1CompletedNCT00000246Phase 2
- Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1CompletedNCT00000245Phase 2
- Carbamazepine Treatment of Cocaine Dependence - 1CompletedNCT00000242Phase 2
- Flupenthixol Decanoate in Methamphetamine Smoking - 1CompletedNCT00000241Phase 2
- Pharmacotherapy and Intensive Treatment - 2CompletedNCT00000218Phase 4
- Pharmacotherapy and Intensive Treatment of Drug Abuse - 1CompletedNCT00000217Phase 2
- Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1CompletedNCT00000216Phase 3
- Treatment Efficacy for Drug Abuse and AIDS Prevention - 2CompletedNCT00000211Phase 2
- Treatment Efficacy for Drug Abuse and AIDS Prevention - 1CompletedNCT00000210Phase 2